what glp-1 drugs are fda approved for weight loss The first ever FDA-approved pill loss. Now on Ro. For Important Safety Information about GLP-1 medications, including Boxed Warning, go to ro.co/safety #wegovy #glp1 The FDA has approved the

12 Although larger-scale studies are yet to explore the effects of GLP-1 RAs on cardiac structure and function, available evidence suggests that GLP-1 RAs may improve systolic and diastolic function in individuals with T2D who are at high risk of CVD and reduce infarct size after acute MI

Results may vary from person to person

Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: the Lira Pump trial-a randomized, double-blinded, placebo-controlled trial

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

But some that are being developed could be available to patients in the next couple of years

Market size estimates from multiple analyst consensus ranges